Great news for the patient community
Approved today: the first ever approved therapy for bronchiectasis in EuropeView quoted post on X
Congratulations investigators, patients and Insmed
Science changes lives
European Commission Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union - Nov 18, 2025
investor.insmed.com/2025-11-18-Eur…